Sartorius Stedim Biotech S.A. (EPA:DIM)
France
· Delayed Price · Currency is EUR 164.60
-5.55 (-3.26%)
Mar 6, 2026, 5:38 PM CET
Sartorius Stedim Biotech Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 2,968 | 2,780 | 2,776 | 3,493 | 2,887 | Upgrade
|
| Revenue Growth (YoY) | 6.74% | 0.16% | -20.53% | 20.98% | 51.14% | Upgrade
|
| Cost of Revenue | 1,622 | 1,573 | 1,542 | 1,675 | 1,334 | Upgrade
|
| Gross Profit | 1,345 | 1,207 | 1,234 | 1,817 | 1,553 | Upgrade
|
| Selling, General & Admin | 662.7 | 650.1 | 617.6 | 612.3 | 531.9 | Upgrade
|
| Research & Development | 133.1 | 144.1 | 129.5 | 132.4 | 110.5 | Upgrade
|
| Other Operating Expenses | 11.4 | 16.5 | 17.5 | 18.2 | -9.6 | Upgrade
|
| Operating Expenses | 807.2 | 810.7 | 764.6 | 762.9 | 632.8 | Upgrade
|
| Operating Income | 538.1 | 396 | 469.4 | 1,054 | 920.2 | Upgrade
|
| Interest Expense | -138.1 | -148 | -115.4 | -18.2 | -10.2 | Upgrade
|
| Interest & Investment Income | 11.6 | 18.9 | 6.2 | 0.5 | 0.3 | Upgrade
|
| Earnings From Equity Investments | -2.2 | -8.6 | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | -7.3 | 6.6 | -13.3 | -32.8 | 12.3 | Upgrade
|
| Other Non Operating Income (Expenses) | -16.1 | -12.9 | -4.3 | -4.6 | -37.1 | Upgrade
|
| EBT Excluding Unusual Items | 386 | 252 | 342.6 | 999.3 | 885.5 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | - | -20.3 | Upgrade
|
| Other Unusual Items | -12.8 | -32.8 | 59.3 | 131.1 | -218.5 | Upgrade
|
| Pretax Income | 373.2 | 219.2 | 401.9 | 1,130 | 646.7 | Upgrade
|
| Income Tax Expense | 107.3 | 40.7 | 89.2 | 250.5 | 232.4 | Upgrade
|
| Earnings From Continuing Operations | 265.9 | 178.5 | 312.7 | 879.9 | 414.3 | Upgrade
|
| Minority Interest in Earnings | -0.3 | -3.4 | -2.4 | -3.8 | 0.1 | Upgrade
|
| Net Income | 265.6 | 175.1 | 310.3 | 876.1 | 414.4 | Upgrade
|
| Net Income to Common | 265.6 | 175.1 | 310.3 | 876.1 | 414.4 | Upgrade
|
| Net Income Growth | 51.69% | -43.57% | -64.58% | 111.41% | 23.36% | Upgrade
|
| Shares Outstanding (Basic) | 97 | 97 | 92 | 92 | 92 | Upgrade
|
| Shares Outstanding (Diluted) | 97 | 97 | 92 | 92 | 92 | Upgrade
|
| Shares Change (YoY) | 0.54% | 5.01% | -0.00% | -0.01% | -0.00% | Upgrade
|
| EPS (Basic) | 2.73 | 1.81 | 3.37 | 9.51 | 4.50 | Upgrade
|
| EPS (Diluted) | 2.73 | 1.81 | 3.37 | 9.51 | 4.50 | Upgrade
|
| EPS Growth | 50.88% | -46.26% | -64.58% | 111.45% | 23.51% | Upgrade
|
| Free Cash Flow | 299 | 475.3 | 272.8 | 181.7 | 377.9 | Upgrade
|
| Free Cash Flow Per Share | 3.07 | 4.91 | 2.96 | 1.97 | 4.10 | Upgrade
|
| Dividend Per Share | 0.690 | 0.690 | 0.690 | 1.440 | 1.260 | Upgrade
|
| Dividend Growth | - | - | -52.08% | 14.29% | 85.29% | Upgrade
|
| Gross Margin | 45.33% | 43.41% | 44.46% | 52.03% | 53.79% | Upgrade
|
| Operating Margin | 18.13% | 14.24% | 16.91% | 30.19% | 31.87% | Upgrade
|
| Profit Margin | 8.95% | 6.30% | 11.18% | 25.08% | 14.35% | Upgrade
|
| Free Cash Flow Margin | 10.08% | 17.10% | 9.83% | 5.20% | 13.09% | Upgrade
|
| EBITDA | 778.1 | 629.3 | 657.7 | 1,197 | 1,031 | Upgrade
|
| EBITDA Margin | 26.22% | 22.64% | 23.70% | 34.27% | 35.73% | Upgrade
|
| D&A For EBITDA | 240 | 233.3 | 188.3 | 142.5 | 111.2 | Upgrade
|
| EBIT | 538.1 | 396 | 469.4 | 1,054 | 920.2 | Upgrade
|
| EBIT Margin | 18.13% | 14.24% | 16.91% | 30.19% | 31.87% | Upgrade
|
| Effective Tax Rate | 28.75% | 18.57% | 22.20% | 22.16% | 35.94% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.